Loading
ST
Stemline Therapeutics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Forman Alan S, was filed 06 Dec 2019.
Stemline Therapeutics Inc: what insiders have been doing
Stemline Therapeutics Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Stemline Therapeutics Inc has had no insider filing for more than a year; the last one goes back to 10 June 2020.
Our records for Stemline Therapeutics Inc go back to 2016, with 2 purchases and 98 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
156
Thresholds
n/a
Buy Volume
€18,116
2 ops. · all time
Sell Volume
€10M
98 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
RevenueUS$445.7k
Net income-US$68.5M-15363.4% margin
Last declaration on 10 June 2020
Declarations156 total
66,346 sharesCommon StockSEC:0001104659-20-071836:0
35,468 sharesCommon StockSEC:0001104659-20-071838:0
600,000 shares0Common StockSEC:0001104659-20-071835:0
1,374,352 sharesCommon StockSEC:0001104659-20-071835:1
88,298 sharesCommon StockSEC:0001104659-20-071826:0
60,121 sharesCommon StockSEC:0001104659-20-071825:0
51,468 sharesCommon StockSEC:0001104659-20-071839:0
200,891 sharesCommon StockSEC:0001104659-20-071832:0
220,000 shares0Common StockSEC:0001104659-20-071837:0
3,024,336 sharesCommon StockSEC:0001104659-20-071837:1
45,000 shares0Common StockSEC:0001104659-20-071841:0
327,878 sharesCommon StockSEC:0001104659-20-071841:1
35,468 sharesCommon StockSEC:0001104659-20-071831:0
272 shares@ US$11.514.4% of flowCommon StockSEC:0001104659-20-057631:0
53,618 shares@ US$4.8820.3% of flowCommon StockSEC:0001104659-20-048399:0
11,524 shares@ US$4.7921.6% of flowCommon StockSEC:0001104659-20-043324:0
2,849 shares@ US$3.884.2% of flowCommon StockSEC:0001104659-20-037012:0
5,011 shares@ US$5.089.6% of flowCommon StockSEC:0001104659-20-033488:0
8,846 shares@ US$4.9216.4% of flowCommon StockSEC:0001104659-20-033488:1
9,487 shares@ US$5.084.7% of flowCommon StockSEC:0001104659-20-033491:0
16,704 shares@ US$4.918.0% of flowCommon StockSEC:0001104659-20-033491:1
20,909 shares@ US$5.097.9% of flowCommon StockSEC:0001104659-20-033489:0
36,542 shares@ US$4.9213.3% of flowCommon StockSEC:0001104659-20-033489:1
1,266 shares@ US$5.008.5% of flowCommon StockSEC:0001104659-20-033490:0
9,147 shares@ US$6.4323.2% of flowCommon StockSEC:0001104659-20-027399:0
25 of 156 declarations
About Stemline Therapeutics Inc
Stemline Therapeutics Inc is a biopharmaceutical company focused on developing treatments for cancer and hematological diseases. It is listed on the NASDAQ.
